Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleen Laul

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
JACS Au|September 27, 2024
Structure-Based Design of CBP/EP300 Degraders: When Cooperativity Overcomes AffinityIván Cheng-Sánchez, Katherine Gosselé, Leonardo Palaferri, et al.
JACS Au|June 27, 2025
Selective CBP/EP300 Bromodomain Inhibitors: Novel Epigenetic Tools to Counter TNF-α-Driven InflammationKatherine A Gosselé, Irene Latino, Eleen Laul, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
Hitting a Moving Target: Simulation and Crystallography Study of ATAD2 Bromodomain BlockersAymeric Dolbois, Laurent Batiste, Lars Wiedmer, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
JACS Au|September 27, 2024
Structure-Based Design of CBP/EP300 Degraders: When Cooperativity Overcomes AffinityIván Cheng-Sánchez, Katherine Gosselé, Leonardo Palaferri, et al.
JACS Au|June 27, 2025
Selective CBP/EP300 Bromodomain Inhibitors: Novel Epigenetic Tools to Counter TNF-α-Driven InflammationKatherine A Gosselé, Irene Latino, Eleen Laul, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
Hitting a Moving Target: Simulation and Crystallography Study of ATAD2 Bromodomain BlockersAymeric Dolbois, Laurent Batiste, Lars Wiedmer, et al.
Pageof 1